c-Raf promotes angiogenesis during normal growth plate maturation

Development (Cambridge)

Volumn 143, Issue 2, 2016, Pages 348-355

  Liu, Eva S ^a,b,c   Raimann, Adalbert ^b,c,d   Chae, Byongsoo Timothy ^b   Martins, Janaina S ^b,c   Baccarini, Manuela ^e   Demay, Marie B ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; c Raf; Chondrocyte apoptosis; Growth plate; Mouse; VEGF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MATURATION; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GROWTH PLATE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UBIQUITINATION; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CHONDROCYTE; CYTOLOGY; EPIPHYSIS PLATE; FEMALE; GENETICS; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; FEMALE; GROWTH PLATE; MALE; MICE; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 84954509420     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.127142     Document Type: Article

References (38)

1. Bradley, E. W. and Drissi, M. H. (2010). WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol. Endocrinol. 24, 1581-1593.
2. Carlevaro, M. F., Cermelli, S., Cancedda, R. and Descalzi Cancedda, F. (2000). Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113, 59-69.
3. Chen, S., Grover, M., Sibai, T., Black, J., Rianon, N., Rajagopal, A., Munivez, E., Bertin, T., Dawson, B., Chen, Y. et al. (2015a). Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol. Genet. Metab. 115, 53-60.
4. Chen, Z., Yue, S. X., Zhou, G., Greenfield, E. M. and Murakami, S. (2015b). ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation. J. Bone Miner. Res. 30, 765-774.
5. Cseh, B., Doma, E. and Baccarini, M. (2014). "RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway. FEBS Lett. 588, 2398-2406.
6. Engsig, M. T., Chen, Q.-J., Vu, T. H., Pedersen, A.-C., Therkidsen, B., Lund, L. R., Henriksen, K., Lenhard, T., Foged, N. T., Werb, Z. et al. (2000). Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151, 879-890.
7. Feliers, D., Duraisamy, S., Barnes, J. L., Ghosh-Choudhury, G. and Kasinath, B. S. (2005). Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am. J. Physiol. Renal Physiol. 288, F521-F529.
8. Gerber, H. P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z. and Ferrara, N. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623-628.
9. Haigh, J. J., Gerber, H. P., Ferrara, N. and Wagner, E. F. (2000). Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127, 1445-1453.
10. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J. and Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037.
11. Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A. and Lyons, K. M. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130, 2779-2791.
12. Jesenberger, V., Procyk, K. J., Ruth, J., Schreiber, M., Theussl, H.-C., Wagner, E. F. and Baccarini, M. (2001). Protective role of Raf-1 in Salmonella-induced macrophage apoptosis. J. Exp. Med. 193, 353-364.
13. Kaneko, Y., Tanzawa, H. and Sato, K. (1994). The proto-oncogene C-raf-1 is highly expressed only in the hypertrophic zone of the growth plate. Calcif. Tissue Int. 54, 426-430.
14. Kimata, M., Michigami, T., Tachikawa, K., Okada, T., Koshimizu, T., Yamazaki, M., Kogo, M. and Ozono, K. (2010). Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway. Bone 47, 938-947.
15. Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336.
16. Lefebvre, V., Garofalo, S., Zhou, G., Metsaranta, M., Vuorio, E. and De Crombrugghe, B. (1994). Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 14, 329-335.
17. Liu, Z., Xu, J., Colvin, J. S. and Ornitz, D. M. (2002). Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16, 859-869.
18. Liu, E. S., Zalutskaya, A., Chae, B. T., Zhu, E. D., Gori, F. and Demay, M. B. (2014). Phosphate interacts with PTHrP to regulate endochondral bone formation. Endocrinology 155, 3750-3756.
19. Livak, K. J. and Schmittgen, T. D. (2001). Analysis ofrelative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
20. Maes, C., Stockmans, I., Moermans, K., Van Looveren, R., Smets, N., Carmeliet, P., Bouillon, R. and Carmeliet, G. (2004). Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest. 113, 188-199.
21. Maes, C., Kobayashi, T., Selig, M. K., Torrekens, S., Roth, S. I., Mackem, S., Carmeliet, G. and Kronenberg, H. M. (2010). Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 19, 329-344.
22. Matsushita, T., Chan, Y. Y., Kawanami, A., Balmes, G., Landreth, G. E. and Murakami, S. (2009). Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol. Cell. Biol. 29, 5843-5857.
23. Miedlich, S. U., Zalutskaya, A., Zhu, E. D. and Demay, M. B. (2010). Phosphate-induced apoptosis ofhypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon ERK1/2 phosphorylation. J. Biol. Chem. 285, 18270-18275.
24. Mikula, M., Schreiber, M., Husak, Z., Kucerova, L., Ruth, J., Wieser, R., Zatloukal, K., Beug, H., Wagner, E. F. and Baccarini, M. (2001). Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20, 1952-1962.
25. Murakami, S., Balmes, G., McKinney, S., Zhang, Z., Givol, D. and de Crombrugghe, B. (2004). Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18, 290-305.
26. Ortega, N., Wang, K., Ferrara, N., Werb, Z. and Vu, T. H. (2010). Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis. Model. Mech. 3, 224-235.
27. Park, M., Yong, Y., Choi, S.-W., Kim, J. H., Lee, J. E. and Kim, D.-W. (2007). Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nat. Cell Biol. 9, 287-298.
28. Provot, S., Kempf, H., Murtaugh, L. C., Chung, U.-I., Kim, D.-W., Chyung, J., Kronenberg, H. M. and Lassar, A. B. (2006). Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 133, 651-662.
29. Provot, S., Nachtrab, G., Paruch, J., Chen, A. P., Silva, A. and Kronenberg, H. M. (2008). A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes. Mol. Cell. Biol. 28, 344-357.
30. Ruan, Q., Han, S., Jiang, W. G., Boulton, M. E., Chen, Z. J., Law, B. K. and Cai, J. (2011). alphaB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells. Mol. Cancer Res. 9, 1632-1643.
31. Sabbagh, Y., Carpenter, T. O. and Demay, M. B. (2005). Hypophosphatemia leads to rickets byimpairing caspase-mediated apoptosis ofhypertrophicchondrocytes. Proc. Natl. Acad. Sci. USA 102, 9637-9642.
32. Sahni, M., Raz, R., Coffin, J. D., Levy, D. and Basilico, C. (2001). STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128, 2119-2129.
33. Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J. M., Richardson, J. A. et al. (2004). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566.
34. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
35. Wilkinson, K. D. (2000). Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11, 141-148.
36. Wojnowski, L., Stancato, L. F., Zimmer, A. M., Hahn, H., Beck, T. W., Larner, A. C., Rapp, U. R. and Zimmer, A. (1998). Craf-1 protein kinase is essential for mouse development. Mech. Dev. 76, 141-149.
37. Wojnowski, L., Stancato, L. F., Larner, A. C., Rapp, U. R. and Zimmer, A. (2000). Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mech. Dev. 91, 97-104.
38. Zalutskaya, A. A., Cox, M. K. and Demay, M. B. (2009). Phosphate regulates embryonic endochondral bone development. J. Cell. Biochem. 108, 668-674.